Related Experiment Video

Updated: Sep 14, 2025

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution
04:14

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution

Published on: April 16, 2019

12.1K

GLP-1RAs and cardiovascular risk reduction in hidradenitis suppurativa: A real-world cohort study

Peichi P Chou1, Charlotte Jeong2, Elaine Ma3

  • 1University of California, Riverside, School of Medicine, Riverside, California, USA.

Journal of the European Academy of Dermatology and Venereology : JEADV
|July 22, 2025
PubMed
Abstract

No abstract available in PubMed .

Keywords:
cardiovascular diseasediabetes mellitusglucagon‐like peptide‐1 receptorhidradenitis suppurativametabolic diseaseobesity

More Related Videos

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
09:49

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy

Published on: December 28, 2021

3.5K
Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
03:42

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF

Published on: March 29, 2024

1.7K

Related Experiment Videos

Last Updated: Sep 14, 2025

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution
04:14

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution

Published on: April 16, 2019

12.1K
Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
09:49

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy

Published on: December 28, 2021

3.5K
Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
03:42

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF

Published on: March 29, 2024

1.7K

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

36
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
36

Articles linked to this work by shared authors, journal, and citation graph.

Tralokinumab Versus Dupilumab for the Treatment of Atopic Dermatitis with Moderate-to-Severe Hand Involvement: A Matching-Adjusted Indirect Comparison.

Dermatology and therapy·2026

Moderate-to-severe chronic spontaneous urticaria is associated with increased risk of immune-mediated diseases: A population-based study.

PloS one·2026

Effectiveness of brodalumab in biologic-experienced adults with moderate to severe plaque psoriasis: a focused narrative review.

The Journal of dermatological treatment·2026

Safety and Efficacy of Deucravacitinib in Japanese Patients With Moderate to Severe Plaque Psoriasis: 5-Year Analysis of the Phase 3 POETYK PSO-1, PSO-4, and Long-Term Extension Trials.

The Journal of dermatology·2026

A scoping review: Community-based interventions for primary prevention of skin cancer.

Dermatology online journal·2026

Treatment patterns for bullous pemphigoid in older adults: A population-based study.

Dermatology online journal·2026

Female genital lichen sclerosus.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

Experience-based recommendations for the diagnosis and management of early-stage nail unit melanoma.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

Optimizing therapy in hidradenitis suppurativa: Combination, sequencing and treat-to-target.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

The future management of HS: People with HS as partners.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

Targeted therapies in pemphigus vulgaris: Emerging horizons beyond rituximab.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

Upcoming novel treatments for hidradenitis suppurativa: An overview of the pipeline.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us